DERMAL LAB LTD has a total of 31 patent applications. Its first patent ever was published in 1965. It filed its patents most often in United Kingdom, Germany and Ireland. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are SHANGHAI LONGXI INVEST CO LTD, ALLART JEAN-CLAUDE and DERMWORX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 7 | |
#2 | Germany | 4 | |
#3 | Ireland | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | France | 2 | |
#7 | Japan | 2 | |
#8 | South Africa | 2 | |
#9 | Belgium | 1 | |
#10 | Denmark | 1 | |
#11 | Finland | 1 | |
#12 | Netherlands | 1 | |
#13 | Norway | 1 | |
#14 | New Zealand | 1 | |
#15 | Sweden | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Object sterilising | |
#6 | Steroids | |
#7 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Whitefield Martin | 10 |
#2 | Yarrow Hyman | 9 |
#3 | Yarrow H | 7 |
#4 | Whitefield M | 7 |
#5 | Maachin Howaitofuiirudo | 2 |
#6 | Yarrow Hyman Dr | 1 |
#7 | Little John Herries | 1 |
#8 | Haiman Yaaro | 1 |
#9 | Whitefield Martin Dr | 1 |
#10 | Haiman Yaarou | 1 |
Publication | Filing date | Title |
---|---|---|
GB8824850D0 | Haemostatic agents | |
GB2097783A | Imidazoles | |
IE44770L | Improvements in and relating to compositions for topical application | |
GB1504007A | Compositions containing dithranol | |
IE43270L | Steroid compositions | |
DE2204366A1 | Steroid esters - contng dihydroxyphenyl residues suitable for topical application | |
DE2204365A1 | Dihydroxyphenyl derivs - inters for topically effective pharmaceuticals | |
GB1326443A | Dihydroxygenzenes | |
GB1191530A | Keratolytic Compositions. | |
GB1155258A | Novel compositions containing complex quaternary ammonium salts | |
IE29322L | Anthracene derivatives; pharmaceuticals | |
CA868321A | Pharmaceutical composition containing triacetate of anthralin |